ArticleOncoTargets and therapy2017

Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer.

Fei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.